Blood coagulation composition comprising calcium lactate as active ingredient and use thereof
A calcium lactate-based composition addresses the limitations of existing hemostatic products by promoting rapid and stable clot formation and preventing adhesions, effectively controlling severe bleeding and surgical adhesions.
Patent Information
- Application Number
- PCT/KR2025/022391
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-26
- Filing Date
- 2025-12-19
- Publication Date
- 2026-07-02
AI Technical Summary
Current hemostatic products fail to effectively control severe bleeding, particularly in compressive hemorrhage, and do not prevent postoperative adhesions, with limitations including inadequate adhesion to wounds, handling issues, and inefficacy under high-pressure bleeding.
A blood coagulation composition comprising calcium lactate as an active ingredient, dispersed on an absorbent carrier, which promotes rapid hemostasis and prevents adhesions by activating coagulation factors and stabilizing blood clots.
The calcium lactate composition effectively stops bleeding and prevents postoperative adhesions by enhancing clot formation and stability, demonstrating superior thrombus formation and transglutaminase activity compared to calcium chloride, and reducing adhesion formation.